Member Info for thomascromwell

Elric, Did Professor O'Neil run a check on Sedermer's Matrixly and found it had no efficacy.

Prospecter, Dim comes to mind!!!!!!!!

Belgrano, To pull the distribution deals for failure before the actual signing of these deals, does not make sense.

Phat, We will see the S/P recover, It would be a different scenario if AxisBiotix had no efficacy, and was the only strand SBTX had. Don't despair!

Toyin, why reiterate the sales of just £75k? The question is does the product work? Growing retention rates at 85%, sales doubling month on month, and you are apologizing for the dismal take-up that now is past history.

What a ton of waffle you are all spouting today! Watch the podcast again and you then may have a more insightful opinion of the value of the company.

SOH must have been influential in the decisions from his own experience with Opti.

Max Factor!

Elric, Thanks, now we know the thinking and how this company is going forward, my sincerest apologies to Stuart Ashman, Thanks again Elric and Stuart, I can sleep more easily.

Elric, The garden path is long, I sincerely hope you demand answers why a ground-breaking product for psoriasis has not been recognized and the dismal sales and marketing of this product, Exchange and Mart would have generated greater sales. £75,000 absolutely pathetic performance from the CEO.

Disappointing, but an 85% retention rate is an achievement, the rate of growth of Axis will gradually snowball as the retention rate suggests.

Spending the rest of the year on tenterhooks, give us a break Elric!

I imagine SOH would love to see sbtx roar ahead, as it is the only financial asset of any worth in the opti portfolio. The decoupling between the two companies may be starting to happen, one going up in price while the other stagnates.

Finally sold my last tranche of OPTI, and re-invested into Skin.

Choleric, Do we have to put up with your drivel?

Choleric, The podcast was illuminating, of particular interest was jaundice which can cause hemorrhoids, please note that SBTX is developing a cream for the condition, together with an applicator.

Why wait for confirmation!

Opti has sweetbiotix, which may or not be happening this side of the complete extinction of humanity, but Sbtx has within the current this year if we are to survive the Tory leadership contest, newsflow, that will propel this company if it is not accumulated by Croda, to a far more respectable share price.

Choleric, Why don't you join Greenpeace and chain yourself to a buoy in the north sea!

A couple of worthy comments on Opti, with its holding in SBTX, are still a valued discussion for this board. I still hold Opti but with a much-reduced holding. Thanks, AquaeSulis.